Population
Patients receiving rocuronium as part of their anaesthesia
Design
Review
Authors
Loading...
Discrepancies in anaphylaxis reporting urge caution in pharmacovigilance interpretation; leaves open the true incidence of rocuronium reactions.
Highlights the statistical challenges and biases in adverse drug reaction surveillance, using rocuronium-induced anaphylaxis as an example.
Laake et al. (2001) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: